|
|
|
|
Archives
|
Entry
|
Author
|
Date
|
Location
|
|
Amylin and Eli Lilly Part Ways on Diabetes Drug; Alkermes Deal Intact
|
Bruce V. Bigelow |
11/08/11 |
San Diego
|
|
Amylin Gets TRO Against Lilly
|
Bruce V. Bigelow |
05/26/11 |
San Diego
|
|
West Wireless Repositions Itself as an Impartial Arbiter, Amylin Makes Headway in Europe, VCs Debate Viability of Venture-Backed Biotech, & More San Diego Life Sciences News
|
Bruce V. Bigelow |
04/21/11 |
San Diego
|
|
Amylin and Takeda Suspend Obesity Study to Consider Metreleptin Data
|
Bruce V. Bigelow |
03/16/11 |
San Diego
|
|
Novartis Buys Alnylam Shares, Xconomy Holds First Ever Health IT Forum, Vertex Alumni Spread Throughout Life Sciences Sector, & More Boston-Area Life Sciences News
|
Erin Kutz |
04/30/10 |
Boston
|
|
Amylin Co-Founder Sides with Rebels in Proxy Fight
|
Juha-Pekka Tikka |
05/12/09 |
San Diego
|
|
Amylin Braces for Proxy Battle Amid Flurry of Filings
|
Bruce V. Bigelow |
04/09/09 |
San Diego
|
|
California Stem Cell Agency Awards Grants, Cohu Buys German Rival, Amylin Gets Go-Ahead, & More San Diego BizTech News
|
Bruce V. Bigelow |
12/15/08 |
San Diego
|
|
Amylin Resurrects Obesity Drug, in New Combination with Diabetes Drug Symlin
|
Luke Timmerman |
10/04/08 |
San Diego
|
|
Page 1 of
1 |
|
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.
© 2007-2012, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Site produced by Andrew Koyfman with design from Rob Hunter.
